-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Amgen, Raises Price Target to $420

Benzinga·07/13/2026 18:22:14
语音播报
UBS analyst Michael Yee maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $400 to $420.